Data / Drug companies / Aripiprazole
Aripiprazole: 49 companies and 266 products in the FDA NDC directory
Aripiprazole is listed in the FDA National Drug Code Directory by 49 companies, with 266 products in commercial distribution. 251 of the products (94.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, orally disintegrating; solution, and the newest product started marketing on September 8, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 49
- Products
- 266
- Generic (ANDA) products
- 251 (94.4%)
- Application numbers
- 28
- Routes
- Oral, Intramuscular
- Brand names
- Abilify, Abilify Maintena, Opipza, Abilify Asimtufii
- openFDA record search
- api.fda.gov
Companies that list aripiprazole
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Remedyrepack Inc. | 13 | tablet | Generic drugs (ANDA) | September 8, 2026 |
| Bryant Ranch Prepack | 12 | tablet | Generic drugs (ANDA) | February 27, 2019 |
| Camber Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | August 8, 2017 |
| Dr. Reddy's Laboratories Inc. | 12 | tablet | Generic drugs (ANDA) | March 16, 2020 |
| Otsuka America Pharmaceutical, Inc. | 12 | tablet; kit | New drug applications (NDA) | February 28, 2025 |
| ScieGen Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | February 25, 2020 |
| Solco Healthcare US, LLC | 12 | tablet | Generic drugs (ANDA) | December 4, 2017 |
| XLCare Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | January 5, 2021 |
| A-S Medication Solutions | 11 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Alembic Pharmaceuticals Inc. | 8 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | July 7, 2016 |
| Alembic Pharmaceuticals Limited | 8 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | May 21, 2015 |
| Coupler LLC | 8 | tablet | Generic drugs (ANDA) | July 10, 2026 |
| Amneal Pharmaceuticals LLC | 7 | tablet; solution | Generic drugs (ANDA) | June 20, 2016 |
| Major Pharmaceuticals | 7 | tablet | Generic drugs (ANDA) | June 20, 2016 |
| Accord Healthcare Inc. | 6 | tablet | Generic drugs (ANDA) | February 15, 2017 |
| Ajanta Pharma USA Inc. | 6 | tablet | Generic drugs (ANDA) | May 30, 2017 |
| American Health Packaging | 6 | tablet | Generic drugs (ANDA) | June 9, 2015 |
| Ascend Laboratories, LLC | 6 | tablet | Generic drugs (ANDA) | February 27, 2019 |
| Aurobindo Pharma Limited | 6 | tablet | Generic drugs (ANDA) | October 8, 2015 |
| AvPAK | 6 | tablet | Generic drugs (ANDA) | April 28, 2016 |
| Exelan Pharmaceuticals Inc. | 6 | tablet | Generic drugs (ANDA) | April 28, 2015 |
| Macleods Pharmaceuticals Limited | 6 | tablet | Generic drugs (ANDA) | October 8, 2016 |
| NorthStar Rx LLC | 6 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Preferred Pharmaceuticals Inc. | 6 | tablet | Generic drugs (ANDA) | August 9, 2023 |
| Torrent Pharmaceuticals Limited | 6 | tablet | Generic drugs (ANDA) | April 28, 2015 |
| Unichem Pharmaceuticals (USA), Inc. | 6 | tablet | Generic drugs (ANDA) | February 21, 2022 |
| Direct_Rx | 4 | tablet | Generic drugs (ANDA) | May 30, 2023 |
| NuCare Pharmaceuticals,Inc. | 4 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Quallent Pharmaceuticals Health LLC | 4 | tablet | Generic drugs (ANDA) | July 19, 2023 |
| Square Pharmaceuticals Limited | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | July 20, 2022 |
| Aurobindo Pharma Limited | 3 | tablet, orally disintegrating; solution | Generic drugs (ANDA) | February 18, 2026 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | June 20, 2016 |
| Carwin Pharmaceutical Associates, LLC | 3 | film, soluble | New drug applications (NDA) | November 1, 2024 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet | Generic drugs (ANDA) | March 16, 2020 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | October 8, 2015 |
| Bionpharma Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | February 7, 2022 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | October 8, 2015 |
| Viona Pharmaceuticals Inc | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | July 20, 2022 |
| Advagen Pharma Ltd | 1 | solution | Generic drugs (ANDA) | October 27, 2022 |
| Apotex Corp. | 1 | solution | Generic drugs (ANDA) | October 8, 2015 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | February 27, 2019 |
| Chartwell RX, LLC | 1 | solution | Generic drugs (ANDA) | October 25, 2022 |
| Lannett Company, Inc. | 1 | solution | Generic drugs (ANDA) | August 17, 2015 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | April 28, 2015 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | June 20, 2016 |
| Quagen Pharmaceuticals LLC | 1 | solution | Generic drugs (ANDA) | December 15, 2025 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | April 28, 2015 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | June 3, 2026 |
| VistaPharm, LLC | 1 | solution | Generic drugs (ANDA) | June 19, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 235 | 88.3% |
| Tablet, orally disintegrating | 14 | 5.3% |
| Solution | 8 | 3% |
| Kit | 4 | 1.5% |
| Film, soluble | 3 | 1.1% |
| Injection, suspension, extended release | 2 | 0.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 251 | 94.4% |
| New drug applications (NDA) | 15 | 5.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Atypical Antipsychotic | 262 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.